Skoči na glavni sadržaj

Ostalo

GUIDELINES FOR TREATMENT OF PRIMARY HEADACHES BY THE CROATIAN SOCIETY FOR NEUROVASCULAR DISORDERS OF THE CROATIAN MEDICAL ASSOCIATION AND CROATIAN SOCIETY FOR PAIN PREVENTION, REFERENCE CENTER FOR THE HEADACHE OF THE MINISTRY OF HEALTH OF THE REPUBLIC OF CROATIA, REFERENCE CENTER CROATIA FOR DIAGNOSIS AND TREATMENT OF ACUTE AND CHRONIC PAIN BY THE MINISTRY OF HEALTH OF REPUBLIC OF CROATIA AND HEADACHE SECTION OF CROATIAN NEUROLOGICAL SOCIETY OF THE CROATIAN MEDICAL ASSOCIATION

VANJA BAŠIĆ KES ; Klinika za neurologiju, Referentni centar Ministarstva zdravstva za neuroimunologiju neurogenetiku, Klinički bolnički centar „Sestre milosrdnice“, Zagreb, Hrvatska
VIŠNJA SUPANC ; Klinika za neurologiju, Referentni centar Ministarstva zdravstva za neuroimunologiju neurogenetiku, Klinički bolnički centar „Sestre milosrdnice“, Zagreb, Hrvatska
LUCIJA ZADRO MATOVINA ; Klinika za neurologiju, Referentni centar Ministarstva zdravstva za neuroimunologiju neurogenetiku, Klinički bolnički centar „Sestre milosrdnice“, Zagreb, Hrvatska
NEVENA GRBIĆ ; Klinika za neurologiju, Referentni centar Ministarstva zdravstva za neuroimunologiju neurogenetiku, Klinički bolnički centar „Sestre milosrdnice“, Zagreb, Hrvatska
IRIS ZAVOREO ; Klinika za neurologiju, Referentni centar Ministarstva zdravstva za neuroimunologiju neurogenetiku, Klinički bolnički centar „Sestre milosrdnice“, Zagreb, Hrvatska
MARIJANA LISAK ; Klinika za neurologiju, Referentni centar Ministarstva zdravstva za neuroimunologiju neurogenetiku, Klinički bolnički centar „Sestre milosrdnice“, Zagreb, Hrvatska
TOMISLAV BREITENFELD ; Klinika za neurologiju, Referentni centar Ministarstva zdravstva za neuroimunologiju neurogenetiku, Klinički bolnički centar „Sestre milosrdnice“, Zagreb, Hrvatska
MARIJANA BOSNAR PURETIĆ ; Klinika za neurologiju, Referentni centar Ministarstva zdravstva za neuroimunologiju neurogenetiku, Klinički bolnički centar „Sestre milosrdnice“, Zagreb, Hrvatska
ARIJANA LOVRENČIĆ HUZJAN ; Klinika za neurologiju, Referentni centar Ministarstva zdravstva za neuroimunologiju neurogenetiku, Klinički bolnički centar „Sestre milosrdnice“, Zagreb, Hrvatska
DAVOR JANČULJAK ; Klinika za neurologiju, Klinički bolnički centar Osijek, Osijek, Hrvatska
DAMIR PETRAVIĆ ; Klinika za neurologiju, Klinički bolnički centar Zagreb, Zagreb, Hrvatska
KORALJKA BAČIĆ BARONICA ; Klinika za neurologiju, Klinička bolnica „Sveti Duh“, Zagreb, Hrvatska
DARIJA MAHOVIĆ LAKUŠIĆ ; Klinika za neurologiju, Klinički bolnički centar Zagreb, Zagreb, Hrvatska
MARISTELA STOJIĆ ; Zavod za neurologiju, Klinička bolnica Dubrava, Zagreb, Hrvatska
MARINA TITLIĆ ; Klinika za neurologiju, Klinički bolnički centar Split, Split, Hrvatska
ZLATKO HUCIKA ; Odjel neurologije, Opća bolnica Zabok, Zabok, Hrvatska
DRAGAN SOLDO ; Dom zdravlja Zagreb-Centar, Zagreb, Hrvatska
VLADIMIRA VULETIĆ ; Klinika za neurologiju, Klinički bolnički centar Rijeka, Rijeka, Hrvatska
ZLATKO TRKANJEC ; Klinika za neurologiju, Referentni centar Ministarstva zdravstva za neuroimunologiju neurogenetiku, Klinički bolnički centar „Sestre milosrdnice“, Zagreb, Hrvatska


Puni tekst: hrvatski pdf 153 Kb

str. 201-210

preuzimanja: 1.134

citiraj


Sažetak

Introduction: Headache is one of the most frequent neurological conditions, so a big need for medications for headache treatment and other methods is needed for acute pain relief and chronic prevention of headaches. Aim: Knowing that headache is one of the most frequent conditions we wanted to summarise its treatment. Methods: We explored MEDLINE searches about the treatment of primary headaches. We also explored the Croatian scientifi c base Hrčak. Results: We found articles on both scientifi c bases, but have chosen only the most systemised. Discussion: According to International Headache Classifi cation there are two main types of headaches: primary headaches (migraine and its subtypes, tensiontype headache and its subtypes, trigeminal autonomic cephalgias) and secondary headaches (attributed to infection, head or neck trauma, cranial or cervical vascular disorders, non-vascular intracranial disorders, substance withdrawal, psychiatric conditions, pain attributed to the disorders of cranium, neck, eyes, ears, nose, sinuses, teeth, mouth or other facial or cervical structure). When managing a diagnosis of primary headache, it is important to make a difference between the primary and secondary headache, manage the right diagnosis of primary headache and decide on the right treatment for the acute or preventive phase of headache. The most used medications in headache treatment are nonspecifi c analgetics which can treat headaches, but also other pain disorders. Specifi c headache medication includes medications which can
treat only specifi c types of headaches. Except for the above, there are other methods in headache treatment which include a change of lifestyle, avoiding provocative factors, acupuncture and treatment with botulinum toxin. Conclusion: For primary headache treatment it is important to establish the right diagnosis and act fast in the treatment of acute headache attacks. For some patients, it is important to start a prophylactic treatment but also try to prevent a medication overuse headache. When treating a headache of any kind it is also important to take a whole picture of a patient and his/hers comorbidities and think about possible side effects. Changing a lifestyle and some complementary methods can help us in treating chronic headaches. We supplemented the guidelines published in 2018 with new drugs that have since been registered for the treatment of acute attacks and prophylaxis of migraine attacks.

Ključne riječi

primary headache; treatment; migraine; tension-type headache; cluster headache

Hrčak ID:

294733

URI

https://hrcak.srce.hr/294733

Datum izdavanja:

27.2.2023.

Podaci na drugim jezicima: hrvatski

Posjeta: 2.098 *